Butterfly Network (BFLY) Net Income Growth (1y) (2021 - 2026)
Butterfly Network (BFLY) Net Income Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.47 Bn | 176.17 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 129.01 Bn | 126.14 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn | 18.55% |
| 4 | Boston Scientific | 68.46 Bn | 67.01 Bn | 3.61 Bn | 99.11% |
| 5 | Edwards Lifesciences | 48.40 Bn | 44.73 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn | 89.28% |
| 7 | GE HealthCare Technologies | 28.36 Bn | 26.07 Bn | 1.98 Bn | -30.10% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.46 Bn | 22.33 Bn | 2.07 Bn | 125.69% |
| 10 | Butterfly Network | 1.77 Bn | 1.63 Bn | 18.29 Mn | 9.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.24% |
| Dec 31, 2025 | 15.58% |
| Sep 30, 2025 | -100.73% |
| Jun 30, 2025 | 11.92% |
| Mar 31, 2025 | 35.82% |
| Dec 31, 2024 | 58.97% |
| Sep 30, 2024 | 38.16% |
| Jun 30, 2024 | 45.22% |
| Mar 31, 2024 | 35.12% |
| Dec 31, 2023 | -30.91% |
| Sep 30, 2023 | 50.01% |
| Jun 30, 2023 | 19.92% |
| Mar 31, 2023 | 24.59% |
| Dec 31, 2022 | -115.58% |
| Sep 30, 2022 | -303.67% |
| Jun 30, 2022 | -1,116.89% |
| Mar 31, 2022 | -6,345.94% |
| Dec 31, 2021 | 31.85% |
| Sep 30, 2021 | 85.29% |
| Jun 30, 2021 | 87.34% |